News & insights

First investment for HERAN HealthTech Fund II: Pharmacelera

2025 has been a remarkable year for HERAN. Together with our partners, teams and portfolio companies, we have taken meaningful steps forward in shaping the future of healthcare.

On October 9th, 2025, we welcomed over 100 investors, founders and stakeholders to our annual Investor Day at De Koolputten in Waasmunster. The event reflected our investment philosophy: HERAN fuels bold innovators whose technologies are transforming healthcare and life sciences.

We are proud to announce the successful exit of icometrix, an AI leader in brain imaging now acquired by GE Healthcare. What began as early conviction in a promising idea grew into a global solution for neurology care. This journey reflects our approach: building long-term partnerships rooted in trust, strategic guidance and a commitment to impact.

GE HealthCare announces intent to acquire icometrix to strengthen neurology portfolio with brain MRI assessment solutions

Aspect Analytics, a leading provider of software for spatial biology data analysis, today announced the successful closing of an oversubscribed € 10 million Series A funding round.

HERAN Partners is very happy to welcome Mercedes Tuin to the team in the role of Partner. As many of us, she combines an education in both sciences and business holding a degree in biomedical sciences and an MBA. She complements this with both extensive operational experience in business development and venture capital within the life sciences sector. 

On August 20th, HERAN hosted an exclusive C-level event for the CEOs, founders, and executives of our portfolio companies. The evening brought together entrepreneurs in an inspiring and informal setting.

Hypervision Surgical is accelerating its mission to transform surgical decision-making.